Idursulfase beta

DB16190InvestigationalProtein Based Therapies

Idursulfase beta is under investigation in clinical trial NCT01645189 (Safety and Efficacy of Hunterase).

Mechanism
Curator reviewed
Also known as
Hunterase · Iduronate 2-sulfatase (a-l-iduronate sulfate sulfatase), human proenzyme produced in cho cells (glycoform beta) · Idursulfase .beta.
Code names
GC1111

Resolves to

Compound
UNII5GCF8EPY6RCAS1271734-34-9
Clinical / RWD
ATCA16AB16
Targets
P22304IDS

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Marketed productAcross 1 country and 1 labeller
Sign in
1ATC codeIncluding every combination product, plus 3 drug categories
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Idursulfase beta, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In